We are trial lawyers who draw on deep technical knowledge, industry insight, and experience litigating across venues to protect our clients’ intellectual property, preserve value, and win precedent-setting victories in every type of dispute.
Our team of more than 100 IP litigators brings trial-tested experience to matters ranging from cutting-edge pharmaceutical and technology patent disputes to the copyright, trademark, and trade secrets cases that reshape industries. We can tailor our teams to match our specific capabilities with each client’s specific needs — no matter the IP at issue. We can also address any combination of IP and related antitrust, contract, and unfair business practices claims.
Adversaries know we win the most complex and high-profile IP matters across the spectrum of district courts and the Federal Circuit, as well as at the International Trade Commission (ITC) and Patent Trial and Appeal Board (PTAB). Our reputation often leads us to take over high-stakes IP cases mid-way, securing victories for clients who had faced long odds. Our appearance on the docket signals to opposing counsel that our client is willing to take the case to trial to win.
The most of any law firm, the honorees were recognized for their work on market-leading transactions and high-stakes litigation and trial victories.
A Latham team led by David Frazier won the “Litigators of the Week” competition, alongside co-counsel at Covington, for their outstanding representation of AbbVie in securing the latest of five patent litigation settlements with generic makers that are set to protect its blockbuster immunology drug Rinvoq until 2037.
Individual lawyers and the firm were shortlisted across nine categories, including D.C. Managing Partner of the Year and D.C. General Litigation Department of the Year.